The Latin America, Middle East and Africa Oncology Information Systems Market is expected to witness market growth of 9.4% CAGR during the forecast period (2022-2028).
Oncology Information System also offers thorough and accurate information about medical and personal histories, clinical diagnoses, existing and anticipated treatment plans, and post-therapy results. These systems keep track of the different ways that patients receive anticancer care. Due to the extremely low likelihood of inconsistencies or errors coming from physical intervention, maintaining electronic records is of utmost importance.
Insufficient data, poor accessibility, unreliability, and difficulties with patient confidentiality are further problems with paper-based medical record systems. These are useless instruments for transdisciplinary patient evaluation & management data exchange and quality assurance monitoring to assure improvement. As a result, it is projected that the necessity to gradually replace paper-based records with digital records in healthcare administration will fuel the expansion of the OIS market.
United Arab Emirates (UAE) has seen an increase in noncommunicable diseases including cancer. The number of cases and fatalities have been rising in the UAE over time, despite screening and early diagnostic initiatives that appear to be far from objective coverage of the targeted respondents. The cancer control strategy for the UAE is being created with specific aims and targets in mind, following WHO and EMRO criteria. The objectives are to treat cancer, lessen its incidence, manage mortality, and improve the results and quality of life for cancer patients. Priorities also include enhancing public health education, early detection, prevention, quick diagnosis, continuity of care, facilitation of treatment, workforce training, performance appraisal, and research.
African countries' awareness of the growing health danger posed by non-communicable diseases (NCDs), such as cancer, was underlined by the Brazzaville Declaration on No communicable Diseases Control and Prevention in the WHO African Region, issued in 20112. There were several pledges among the signatories, including the creation of prevention and control plans, improving their health systems to reduce the burden of NCDs, raising money to fight these diseases, and supporting their national health information systems to collect data about NCDs and their risk factors.
The Brazil market dominated the LAMEA Oncology Information Systems Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $60.9 Million by 2028. The Argentina market is experiencing a CAGR of 9.9% during (2022-2028). Additionally, The UAE market is expected to exhibit a CAGR of 9.1% during (2022-2028).
Based on Offering, the market is segmented into Solutions (Patient Information Systems and Treatment Planning Systems) and Professional Services. Based on Application, the market is segmented into Medical Oncology, Radiation Oncology, and Surgical Oncology. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation (Cerner Corporation), Koninklijke Philips N.V., Varian Medical Systems, Inc. (Siemens Healthineers), ViewRay, Inc., Accuray, Incorporated, Elekta AB, RaySearch Laboratories AB (Nasdaq, Inc.), Brainlab AG, DOSIsoft SA (Institut de cancérologie Gustave Roussy), and MIM Software Inc.
By Offering
Oncology Information System also offers thorough and accurate information about medical and personal histories, clinical diagnoses, existing and anticipated treatment plans, and post-therapy results. These systems keep track of the different ways that patients receive anticancer care. Due to the extremely low likelihood of inconsistencies or errors coming from physical intervention, maintaining electronic records is of utmost importance.
Insufficient data, poor accessibility, unreliability, and difficulties with patient confidentiality are further problems with paper-based medical record systems. These are useless instruments for transdisciplinary patient evaluation & management data exchange and quality assurance monitoring to assure improvement. As a result, it is projected that the necessity to gradually replace paper-based records with digital records in healthcare administration will fuel the expansion of the OIS market.
United Arab Emirates (UAE) has seen an increase in noncommunicable diseases including cancer. The number of cases and fatalities have been rising in the UAE over time, despite screening and early diagnostic initiatives that appear to be far from objective coverage of the targeted respondents. The cancer control strategy for the UAE is being created with specific aims and targets in mind, following WHO and EMRO criteria. The objectives are to treat cancer, lessen its incidence, manage mortality, and improve the results and quality of life for cancer patients. Priorities also include enhancing public health education, early detection, prevention, quick diagnosis, continuity of care, facilitation of treatment, workforce training, performance appraisal, and research.
African countries' awareness of the growing health danger posed by non-communicable diseases (NCDs), such as cancer, was underlined by the Brazzaville Declaration on No communicable Diseases Control and Prevention in the WHO African Region, issued in 20112. There were several pledges among the signatories, including the creation of prevention and control plans, improving their health systems to reduce the burden of NCDs, raising money to fight these diseases, and supporting their national health information systems to collect data about NCDs and their risk factors.
The Brazil market dominated the LAMEA Oncology Information Systems Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $60.9 Million by 2028. The Argentina market is experiencing a CAGR of 9.9% during (2022-2028). Additionally, The UAE market is expected to exhibit a CAGR of 9.1% during (2022-2028).
Based on Offering, the market is segmented into Solutions (Patient Information Systems and Treatment Planning Systems) and Professional Services. Based on Application, the market is segmented into Medical Oncology, Radiation Oncology, and Surgical Oncology. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation (Cerner Corporation), Koninklijke Philips N.V., Varian Medical Systems, Inc. (Siemens Healthineers), ViewRay, Inc., Accuray, Incorporated, Elekta AB, RaySearch Laboratories AB (Nasdaq, Inc.), Brainlab AG, DOSIsoft SA (Institut de cancérologie Gustave Roussy), and MIM Software Inc.
Scope of the Study
Market Segments Covered in the Report:
By Offering
- Solutions
- Patient Information Systems
- Treatment Planning Systems
- Professional Services
- Medical Oncology
- Radiation Oncology
- Surgical Oncology
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Oracle Corporation (Cerner Corporation)
- Koninklijke Philips N.V.
- Varian Medical Systems, Inc. (Siemens Healthineers)
- ViewRay, Inc.
- Accuray, Incorporated
- Elekta AB
- RaySearch Laboratories AB (Nasdaq, Inc.)
- Brainlab AG
- DOSIsoft SA (Institut de cancérologie Gustave Roussy)
- MIM Software Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Oncology Information Systems Market by Offering
Chapter 5. LAMEA Oncology Information Systems Market by Application
Chapter 6. LAMEA Oncology Information Systems Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Oracle Corporation (Cerner Corporation)
- Koninklijke Philips N.V.
- Varian Medical Systems, Inc. (Siemens Healthineers)
- ViewRay, Inc.
- Accuray, Incorporated
- Elekta AB
- RaySearch Laboratories AB (Nasdaq, Inc.)
- Brainlab AG
- DOSIsoft SA (Institut de cancérologie Gustave Roussy)
- MIM Software Inc.
Methodology
LOADING...
